Literature DB >> 31143944

Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.

William C Goedel1, Maximilian R F King1, Mark N Lurie1, Sandro Galea2, Jeffrey P Townsend3,4,5, Alison P Galvani3,4,6, Samuel R Friedman7, Brandon D L Marshall1.   

Abstract

BACKGROUND: Syringe services programs (SSPs) are effective venues for delivering harm-reduction services to people who inject drugs (PWID). However, SSPs often face significant barriers to implementation, particularly in the absence of known human immunodeficiency virus (HIV) outbreaks.
METHODS: Using an agent-based model, we simulated HIV transmission in Scott County, Indiana, a rural county with a 1.7% prevalence of injection drug use. We compared outcomes arising in the absence of an SSP, in the presence of a pre-existing SSP, and with implementation of an SSP after the detection of an HIV outbreak among PWID over 5 years following the introduction of a single infection into the network.
RESULTS: In the absence of an SSP, the model predicted an average of 176 infections among PWID over 5 years or an incidence rate of 12.1/100 person-years. Proactive implementation averted 154 infections and decreased incidence by 90.3%. With reactive implementation beginning operations 10 months after the first infection, an SSP would prevent 107 infections and decrease incidence by 60.8%. Reductions in incidence were also observed among people who did not inject drugs.
CONCLUSIONS: Based on model predictions, proactive implementation of an SSP in Scott County had the potential to avert more HIV infections than reactive implementation after the detection of an outbreak. The predicted impact of reactive SSP implementation was highly dependent on timely implementation after detecting the earliest infections. Consequently, there is a need for expanded proactive SSP implementation in the context of enhanced monitoring of outbreak vulnerability in Scott County and similar rural contexts.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; agent-based modeling; injection drug use; rural health; syringe services

Mesh:

Substances:

Year:  2020        PMID: 31143944      PMCID: PMC7319062          DOI: 10.1093/cid/ciz321

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies.

Authors:  Alex H Kral; Kimberly Page-Shafer; Brian R Edlin; Timothy Kellogg; Elise Riley; Lauren Gee; Andrew Moss; Michael Busch; Jeffrey D Klausner; James Dilley; Willi McFarland
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

2.  Threading the Needle--How to Stop the HIV Outbreak in Rural Indiana.

Authors:  Steffanie A Strathdee; Chris Beyrer
Journal:  N Engl J Med       Date:  2015-06-24       Impact factor: 91.245

3.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Authors:  Jonathan A C Sterne; Miguel A Hernán; Bruno Ledergerber; Kate Tilling; Rainer Weber; Pedram Sendi; Martin Rickenbach; James M Robins; Matthias Egger
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

4.  Human immunodeficiency virus transmission at each step of the care continuum in the United States.

Authors:  Jacek Skarbinski; Eli Rosenberg; Gabriela Paz-Bailey; H Irene Hall; Charles E Rose; Abigail H Viall; Jennifer L Fagan; Amy Lansky; Jonathan H Mermin
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

Review 5.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

6.  Prevalence of HIV and risky sexual behaviors among rural drug users: does age matter?

Authors:  Richard A Crosby; Carrie B Oser; Carl G Leukefeld; Jennifer R Havens; April Young
Journal:  Ann Epidemiol       Date:  2012-08-14       Impact factor: 3.797

7.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

Review 8.  HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.

Authors:  Don C Des Jarlais; Thomas Kerr; Patrizia Carrieri; Jonathan Feelemyer; Kamyar Arasteh
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

9.  Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.

Authors:  Steve E Bellan; Jonathan Dushoff; Alison P Galvani; Lauren Ancel Meyers
Journal:  PLoS Med       Date:  2015-03-17       Impact factor: 11.069

Review 10.  Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.

Authors:  Louisa Degenhardt; Amy Peacock; Samantha Colledge; Janni Leung; Jason Grebely; Peter Vickerman; Jack Stone; Evan B Cunningham; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Paul Griffiths; Richard P Mattick; Matthew Hickman; Sarah Larney
Journal:  Lancet Glob Health       Date:  2017-10-23       Impact factor: 26.763

View more
  5 in total

1.  A Systematic Review of Simulation Models to Track and Address the Opioid Crisis.

Authors:  Magdalena Cerdá; Mohammad S Jalali; Ava D Hamilton; Catherine DiGennaro; Ayaz Hyder; Julian Santaella-Tenorio; Navdep Kaur; Christina Wang; Katherine M Keyes
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 6.222

2.  The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study.

Authors:  Xiao Zang; Williams C Goedel; Sam E Bessey; Mark N Lurie; Sandro Galea; Alison P Galvani; Samuel R Friedman; Bohdan Nosyk; Brandon D L Marshall
Journal:  AIDS       Date:  2022-02-24       Impact factor: 4.632

3.  Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017.

Authors:  Jared L Sawyer; Shikhar Shrestha; Jennifer C Pustz; Robert Gottlieb; Deborah Nichols; Michelle Van Handel; Cailyn Lingwall; Thomas J Stopka
Journal:  Prev Med Rep       Date:  2021-08-27

4.  Assessment of Tennessee's county-level vulnerability to hepatitis C virus and HIV outbreaks using socioeconomic, healthcare, and substance use indicators.

Authors:  Jessica Vakili; Lindsey Sizemore; Peter F Rebeiro; Ben Tyndall; Pamela Talley; Kristyn Whaley; Meredith Brantley
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

5.  Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak.

Authors:  Jesse L Yedinak; Yu Li; Maxwell S Krieger; Katharine Howe; Colleen Daley Ndoye; Hyunjoon Lee; Anna M Civitarese; Theodore Marak; Elana Nelson; Elizabeth A Samuels; Philip A Chan; Thomas Bertrand; Brandon D L Marshall
Journal:  Int J Drug Policy       Date:  2021-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.